Integra LifeSciences Holdings Corporation

IART · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$246,375$276,402$456,661$513,448
Short-Term Investments$27,192$32,694$0$0
Receivables$272,370$259,327$263,465$231,831
Inventory$429,090$389,608$324,583$317,386
Other Curr. Assets$106,654$100,005$116,789$91,051
Total Curr. Assets$1,081,681$1,058,036$1,161,498$1,153,716
Property Plant & Equip (Net)$549,765$496,383$459,586$396,246
Goodwill$1,096,952$1,055,462$1,038,881$1,013,458
Intangibles$1,207,588$1,067,833$1,126,609$1,145,573
Long-Term Investments$38,302$30,710$567,341$6,477
Tax Assets$34,923$46,080$45,994$56,950
Other NC Assets$28,213$27,484-$510,151$9,963
Total NC Assets$2,955,743$2,723,952$2,728,260$2,628,667
Other Assets$0$0$0$0
Total Assets$4,037,424$3,781,988$3,889,758$3,782,383
Liabilities
Payables$82,502$92,326$102,100$61,837
Short-Term Debt$621,616$29,815$67,373$74,550
Tax Payable$0$0$0$0
Deferred Revenue$10,483$8,540$7,253$5,295
Other Curr. Liab.$207,525$176,299$144,180$198,339
Total Curr. Liab.$922,126$306,980$320,906$340,021
LT Debt$1,362,947$1,651,867$1,562,610$1,591,512
Deferred Rev, NC$9,200$7,700$8,800$6,700
Deferred Tax Liab, NC$60,833$35,317$63,338$45,788
Other NC Liab.$137,038$192,240$138,501$120,258
Total NC Liab.$1,570,018$1,887,124$1,764,449$1,757,558
Other Liabilities$0$0$0$0
Cap. Leases$181,470$182,133$172,044$105,104
Total Liabilities$2,492,144$2,194,104$2,085,355$2,097,579
Equity
Pref Stock$0$0$0$0
Common Stock$916$909$905$896
Retained Earnings$939,915$946,859$879,118$698,568
AOCI-$27,571-$15,106$10,265-$45,155
Other Equity$632,020$655,222$914,115$1,030,495
Total Equity$1,545,280$1,587,884$1,804,403$1,684,804
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$4,037,424$3,781,988$3,889,758$3,782,383
Net Debt$1,738,188$1,405,280$1,173,322$1,152,614
Integra LifeSciences Holdings Corporation (IART) Financial Statements & Key Stats | AlphaPilot